TrialShare is a transformative approach to data-sharing that enables clinical trial transparency. TrialShare provides clinical trial investigators the unprecedented ability to access de-identified study data, review published analysis methods, and perform real-time, interactive graphical analyses in collaboration with other researchers. Immune Tolerance Network (ITN) TrialShare shares information about ITN's clinical studies and specimen bio-repository. Data and analysis code underlying ITN-published manuscripts are publicly available with the goal of promoting transparency, reproducibility, and scientific collaboration.

More information about this resource is available at TrialShare

Main Areas of Focus

  • To advance the clinical application of immune tolerance therapies and biomarker development
  • To perform high quality clinical trials integrated with mechanism-based research with a focus on allergy, transplantation, and autoimmune disease


  • Data and analysis code underlying ITN-published manuscripts
  • Biological specimens from well-phenotyped study participants
  • Trialshare’s tools allow researchers to:
    • Find relevant datasets
    • Filter and sort data
    • Create participant groups
    • Visualize data through graphs
    • Download datasets
    • Search the specimen repository and download reports on available specimens based on custom criteria

Collaboration Opportunities

  • Data sharing
  • Sample sharing
  • Specimen bio-repository